PubAg

Main content area

Search

15  Search Results

1 - 15 of 15
Number of results to display per page

Search Results

1. Childhood vaccines and Kawasaki disease, Vaccine Safety Datalink, 1996-2006

Author:
Abrams, Joseph Y.; Weintraub, Eric S.; Baggs, James M.; McCarthy, Natalie L.; Schonberger, Lawrence B.; Lee, Grace M.; Klein, Nicola P.; Belongia, Edward A.; Jackson, Michael L.; Naleway, Allison L.; Nordin, James D.; Hambidge, Simon J.; Belay, Ermias D.
Source:
Vaccine 2015 v.33 no.2 pp. 382-387
ISSN:
0264-410X
Subject:
United States,   etc   ; childhood; children; disease incidence; etiology; protective effect; risk factors; vaccination; vaccines;     Show all 9 Subjects
Abstract:
... Kawasaki disease is a childhood vascular disorder of unknown etiology. Concerns have been raised about vaccinations being a potential risk factor for Kawasaki disease.Data from the Vaccine Safety Datalink were collected on children aged 0–6 years at seven managed care organizations across the United States. Defining exposure as one of several time periods up to 42 days after vaccination, we conduc ...
DOI:
10.1016/j.vaccine.2014.10.044

2. Deaths following vaccination: What does the evidence show?

Author:
Miller, Elaine R.; Moro, Pedro L.; Cano, Maria; Shimabukuro, Tom T.
Source:
Vaccine 2015 v.33 no.29 pp. 3288-3292
ISSN:
0264-410X
Subject:
United States,   etc   ; Internet; Variola virus; Yellow fever virus; adults; adverse effects; anaphylaxis; cardiomyopathy; case studies; children; death; eczema; encephalitis; influenza; live vaccines; monitoring; myocarditis; people; public health; risk; syncope; vaccination;     Show all 22 Subjects
Abstract:
... Vaccines are rigorously tested and monitored and are among the safest medical products we use. Millions of vaccinations are given to children and adults in the United States each year. Serious adverse reactions are rare. However, because of the high volume of use, coincidental adverse events including deaths, that are temporally associated with vaccination, do occur. When death occurs shortly foll ...
DOI:
10.1016/j.vaccine.2015.05.023
PubMed:
26004568
PubMed Central:
PMC4599698

3. Effectiveness and impact of rotavirus vaccines in Europe, 2006–2014

Author:
Karafillakis, Emilie; Hassounah, Sondus; Atchison, Christina
Source:
Vaccine 2015 v.33 no.18 pp. 2097-2107
ISSN:
0264-410X
Subject:
United States,   etc   ; Rotavirus; children; clinical trials; databases; gastroenteritis; health services; public health; systematic review; vaccination; vaccines; Europe; Latin America;     Show all 13 Subjects
Abstract:
... Prior to the introduction of rotavirus vaccines in 2006, rotavirus was the leading cause of severe gastroenteritis among European children <5 years of age. We conducted a systematic review of the published literature to examine the effectiveness and impact of rotavirus vaccines in Europe following the first eight years of routine use. Four publication databases were searched, yielding 276 unique c ...
DOI:
10.1016/j.vaccine.2015.03.016

4. Effect of multiple, simultaneous vaccines on polio seroresponse and associated health outcomes

Author:
Broderick, Michael P.; Oberste, M. Steven; Moore, Deborah; Romero-Steiner, Sandra; Hansen, Christian J.; Faix, Dennis J.
Source:
Vaccine 2015 v.33 no.24 pp. 2842-2848
ISSN:
0264-410X
Subject:
United States,   etc   ; blood serum; children; infants; seroconversion; vaccination; vaccines;     Show all 7 Subjects
Abstract:
... Administration of multiple simultaneous vaccines to infants, children, and military recruits is not uncommon. However, little research exists to examine associated serological and health effects, especially in adults.We retrospectively examined 416 paired serum specimens from U.S. military subjects who had received the inactivated polio vaccine (IPV) alone or in combination with either 1 other vac ...
DOI:
10.1016/j.vaccine.2014.07.088

5. Estimates of pertussis vaccine effectiveness in United States air force pediatric dependents

Author:
Wolff, Greg; Bell, Michael; Escobar, James; Ruiz, Stefani
Source:
Vaccine 2015 v.33 no.28 pp. 3228-3233
ISSN:
0264-410X
Subject:
United States,   etc   ; Centers for Disease Control and Prevention; case-control studies; children; compliance; confidence interval; disease prevalence; patients; vaccination; vaccines;     Show all 10 Subjects
Abstract:
... Pertussis vaccination compliance is critical for reduction in the prevalence of disease; however, the current acellular pertussis vaccine may not provide sufficient protection from infection. This study examined acellular pertussis vaccine effectiveness (VE) for Air Force dependents less than 12 years of age.We conducted a case-control study among Air Force pediatric dependents from 2011 to 2013, ...
DOI:
10.1016/j.vaccine.2015.04.084

6. Estimating the herd immunity effect of rotavirus vaccine

Author:
Pollard, Suzanne L.; Malpica-Llanos, Tanya; Friberg, Ingrid K.; Fischer-Walker, Christa; Ashraf, Sania; Walker, Neff
Source:
Vaccine 2015 v.33 no.32 pp. 3795-3800
ISSN:
0264-410X
Subject:
United States,   etc   ; children; death; diarrhea; gastroenteritis; herd immunity; herds; markets; meta-analysis; morbidity; mortality; vaccination; vaccines; Latin America;     Show all 14 Subjects
Abstract:
... Diarrhea is one of the leading causes of death in children under 5, and an estimated 39% of these deaths are attributable to rotavirus. Currently two live, oral rotavirus vaccines have been introduced on the market; however, the herd immunity effect associated with rotavirus vaccine has not yet been quantified. The purpose of this meta-analysis was to estimate the herd immunity effects associated ...
DOI:
10.1016/j.vaccine.2015.06.064

7. Evaluation of anthrax vaccine safety in 18 to 20 year olds: A first step towards age de-escalation studies in adolescents

Author:
King, James C.; Gao, Yonghong; Quinn, Conrad P.; Dreier, Thomas M.; Vianney, Cabrini; Espeland, Eric M.
Source:
Vaccine 2015 v.33 no.21 pp. 2470-2476
ISSN:
0264-410X
Subject:
United States,   etc   ; Bacillus anthracis; adolescents; anthrax; antibodies; children; databases; disease control; elderly; ethics; immune response; injection site; spores; vaccination; vaccines;     Show all 15 Subjects
Abstract:
... Anthrax vaccine adsorbed (AVA, BioThrax®) is recommended for post-exposure prophylaxis administration for the US population in response to large-scale Bacillus anthracis spore exposure. However, no information exists on AVA use in children and ethical barriers exist to performing pre-event pediatric AVA studies. A Presidential Ethics Commission proposed a potential pathway for such studies utilizi ...
DOI:
10.1016/j.vaccine.2015.03.071

8. Immune overload: Parental attitudes toward combination and single antigen vaccines

Author:
Hulsey, Ella; Bland, Tami
Source:
Vaccine 2015 v.33 no.22 pp. 2546-2550
ISSN:
0264-410X
Subject:
United States,   etc   ; antigens; attitudes and opinions; children; decision making; fearfulness; immune system; parents; psychological stress; secondary infection; vaccination; vaccines;     Show all 12 Subjects
Abstract:
... Parental concerns have led to a recent decline in immunization coverage, resulting in outbreaks of diseases that were once under control in the US. As the CDC vaccination schedule continues to increase in complexity, the number of required injections per office visit increases as well. Some parents perceive that there is trauma associated with the administration of multiple injections, and researc ...
DOI:
10.1016/j.vaccine.2015.04.020

9. Incidence of medically attended influenza infection and cases averted by vaccination, 2011/2012 and 2012/2013 influenza seasons

Author:
Jackson, Michael L.; Jackson, Lisa A.; Kieke, Burney; McClure, David; Gaglani, Manjusha; Murthy, Kempapura; Malosh, Ryan; Monto, Arnold; Zimmerman, Richard K.; Foppa, Ivo M.; Flannery, Brendan; Thompson, Mark G.
Source:
Vaccine 2015 v.33 no.39 pp. 5181-5187
ISSN:
0264-410X
Subject:
United States,   etc   ; adults; children; influenza; monitoring; people; vaccination; vaccines;     Show all 8 Subjects
Abstract:
... We estimated the burden of outpatient influenza and cases prevented by vaccination during the 2011/2012 and 2012/2013 influenza seasons using data from the United States Influenza Vaccine Effectiveness (US Flu VE) Network.We defined source populations of persons who could seek care for acute respiratory illness (ARI) at each of the five US Flu VE Network sites. We identified all members of the sou ...
DOI:
10.1016/j.vaccine.2015.07.098
PubMed:
26271827
PubMed Central:
PMC5843472

10. Influenza vaccination type, live, attenuated influenza vaccine (LAIV) versus inactivated influenza vaccine (IIV), received by children, United States, 2011−12 through 2013−14 influenza seasons

Author:
Kahn, Katherine E.; Santibanez, Tammy A.; Zhai, Yusheng; Singleton, James A.
Source:
Vaccine 2015 v.33 no.39 pp. 5196-5203
ISSN:
0264-410X
Subject:
United States,   etc   ; Blacks; Whites; chi-square distribution; children; confidence interval; health policy; income; influenza; poverty; regression analysis; t-test; vaccination; vaccines;     Show all 14 Subjects
Abstract:
... Influenza vaccines available for children in the United States include inactivated influenza vaccine (IIV) and live, attenuated influenza vaccine (LAIV). Objectives of this study were to quantify proportions of IIV and LAIV received by vaccinated children, and examine associations between vaccine type received and demographic characteristics.National Immunization Survey-Flu (NIS-Flu) parental repo ...
DOI:
10.1016/j.vaccine.2015.07.064
PubMed:
26238724
PubMed Central:
PMC4597891

11. Initiation & completion rates of hepatitis A vaccination among US pediatric populations born between 2005 and 2009

Author:
Weiss, Thomas; Zhang, Dongmu; Borse, Nagesh N.; Walter, Emmanuel B.
Source:
Vaccine 2015 v.33 no.48 pp. 6871-6877
ISSN:
0264-410X
Subject:
United States,   etc   ; children; databases; health services; hepatitis A; observational studies; pediatricians; vaccination; vaccines;     Show all 9 Subjects
Abstract:
... To estimate hepatitis A vaccine series initiation and completion rates, assess time to vaccination, identify missed opportunities for the hepatitis A vaccine series, and examine factors associated with hepatitis A vaccine series initiation and completion.We conducted a retrospective, observational study using three healthcare claims databases separately. The study population was comprised of child ...
DOI:
10.1016/j.vaccine.2015.07.065

12. Interventions to increase influenza vaccination rates in children with high-risk conditions—A systematic review

Author:
Aigbogun, N.W.; Hawker, J.I.; Stewart, A.
Source:
Vaccine 2015 v.33 no.6 pp. 759-770
ISSN:
0264-410X
Subject:
United States,   etc   ; elderly; at-risk population; morbidity; cohort studies; vaccines; systematic review; vaccination; chronic diseases; children; asthma; mortality; randomized clinical trials; education; influenza; databases;     Show all 16 Subjects
Abstract:
... Influenza is a common cause of morbidity and mortality, especially among the elderly and those with certain chronic diseases. Annual influenza vaccination is recommended for individuals in at-risk groups, but rates of vaccination are particularly low in children with high-risk conditions (HRCs).To conduct a systematic review of studies that have examined interventions aimed at improving influenza ...
DOI:
10.1016/j.vaccine.2014.12.013

13. Maternal benefits of immunization during pregnancy

Author:
Swamy, Geeta K.; Beigi, Richard H.
Source:
Vaccine 2015 v.33 no.47 pp. 6436-6440
ISSN:
0264-410X
Subject:
United States,   etc   ; Centers for Disease Control and Prevention; abortion (animals); adolescents; adults; children; congenital abnormalities; low birth weight; morbidity; mortality; neonates; passive immunity; pregnancy outcome; pregnant women; premature birth; risk factors; vaccination; vaccines;     Show all 18 Subjects
Abstract:
... The US Centers for Disease Control & Prevention currently recommend routine immunization to prevent 17 vaccine-preventable diseases that occur in infants, children, adolescents, or adults. Pregnant women are at particularly high risk for morbidity and mortality related to several vaccine-preventable diseases. Furthermore, such illnesses are also associated with adverse pregnancy outcomes such as s ...
DOI:
10.1016/j.vaccine.2015.08.035

14. Pneumococcal disease prevention among adults: Strategies for the use of pneumococcal vaccines

Author:
Pilishvili, Tamara; Bennett, Nancy M.
Source:
Vaccine 2015 v.33 pp. D60
ISSN:
0264-410X
Subject:
United States,   etc   ; Streptococcus pneumoniae; bacterial pneumonia; burden of disease; children; disease prevention; elderly; issues and policy; morbidity; mortality; polysaccharides; vaccination; vaccines;     Show all 13 Subjects
Abstract:
... Use of the pneumococcal conjugate vaccines among children in the US since 2000 has dramatically reduced pneumococcal disease burden among adults. Significant vaccine-preventable morbidity and mortality from pneumococcal infections still remains, especially among older adults. The US Advisory Committee on Immunization Practices (ACIP) has recently recommended the routine use of both pneumococcal co ...
DOI:
10.1016/j.vaccine.2015.05.102

15. Vaccine hesitancy

Author:
Salmon, Daniel A.; Dudley, Matthew Z.; Glanz, Jason M.; Omer, Saad B.
Source:
Vaccine 2015 v.33 pp. D66
ISSN:
0264-410X
Subject:
United States,   etc   ; Haemophilus influenzae; children; corporations; parents; physicians; pregnant women; public health; risk communication; vaccination; vaccines; wastes;     Show all 12 Subjects
Abstract:
... Vaccine hesitancy reflects concerns about the decision to vaccinate oneself or one’s children. There is a broad range of factors contributing to vaccine hesitancy, including the compulsory nature of vaccines, their coincidental temporal relationships to adverse health outcomes, unfamiliarity with vaccine-preventable diseases, and lack of trust in corporations and public health agencies. Although v ...
DOI:
10.1016/j.vaccine.2015.09.035